Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis

Arthritis Research and Therapy

Volumn 6, Issue 1, 2003, Pages

  Jarvis, James N ^a   Dozmorov, Igor ^b   Jiang, Kaiyu ^a   Frank, Mark Barton ^b   Szodoray, Peter ^c   Alex, Philip ^b   Centola, Michael ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

arthritis; autoimmunity; bioinformatics; juvenile rheumatoid arthritis; microarray

Indexed keywords

EID: 85182493459     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1018     Document Type: Article

References (44)

1. Jarvis JN: Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol. 1998, 10: 459-467. DOI: 10.1097/00002281-199809000-00011
2. Arend WP: The innate immune system in rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2224-2234. 10.1002/1529-0131(200110)44:10<2224::AID-ART384>3.3.CO;2-8. DOI: 10.1002/1529-0131(200110)44:10<2224::AID-ART384>3.0.CO;2-H
3. Lo D, Feng L, Li L, Carson MJ, Crowley M, Pauza M, Nguyen A, Reilly CR: Integrating innate and adaptive immunity in the whole animal. Immunol Rev. 1999, 169: 225-239. DOI: 10.1111/j.1600-065X.1999.tb01318.x
4. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science. 1996, 72: 50-53. DOI: 10.1126/science.272.5258.50
5. Warrington KJ, Seisuke T, Goronzy JJ, Weyand CM: CD4+, CD28-T cells in rheumatoid arthritis patients combine features of innate and adaptive immune systems. Arthritis Rheum. 2001, 44: 13-20. 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6. DOI: 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6
6. Jarvis JN: Juvenile rheumatoid arthritis: a guide for practitioners. Pediatr Ann. 2002, 31: 437-446. DOI: 10.3928/0090-4481-20020701-08
7. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A: Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001, 10: 1793-1805. 10.1093/hmg/10.17.1793. DOI: 10.1093/hmg/10.17.1793
8. Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001, 10: 445-456. 10.1093/hmg/10.5.445. DOI: 10.1093/hmg/10.5.445
9. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA. 1997, 94: 2150-2155. 10.1073/pnas.94.6.2150. DOI: 10.1073/pnas.94.6.2150
10. Cassidy JT, Levinson JE, Brewer EJ: The development of classification criteria for children with juvenile rheumatoid arthritis. Bull Rheum Dis. 1989, 38: 1-7.
11. Jarvis JN, Pousak T, Krenz M: Detection of IgM rheumatoid factors by ELISA in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities. Pediatrics. 1992, 90: 945-949.
12. Brewer EJ, Giannini EH, Kuzmina N, Alekseev L: Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the USA–USSR double-blind controlled trial. N Engl J Med. 1986, 314: 1269-1276. DOI: 10.1056/NEJM198605153142001
13. Jarvis JN, Pousak T, Krenz M, Iobidze MV, Taylor H: Complement activation and immune complexes in juvenile rheumatoid arthritis. J Rheumatol. 1993, 20: 114-117.
14. Jarvis JN, Iobidze M, Taylor H, Krenz M: Complement activation and immune complexes in children with polyarticular JRA: a longitudinal study. J Rheumatol. 1994, 21: 1124-1127.
15. Dozmorov I, Centola M: An associative of gene expression array data. Bioinformatics. 2003, 19: 204-211. 10.1093/bioinformatics/19.2.204. DOI: 10.1093/bioinformatics/19.2.204
16. Rocke DM, Durbin B: A model for measurement error for gene expression arrays. Comput Biol. 2001, 8: 557-569. 10.1089/106652701753307485. DOI: 10.1089/106652701753307485
17. Zien A, Aigner T, Zimmer R, Lengauer T: Centralization: a new method for the normalization of gene expression data. Bioinformatics. 2001, Suppl 1: S323-331. DOI: 10.1093/bioinformatics/17.suppl_1.S323
18. Lee ML, Kuo FC, Whitmore GA, Sklar J: Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA. 2000, 97: 9834-9839. 10.1073/pnas.97.18.9834. DOI: 10.1073/pnas.97.18.9834
19. Chikanza IC: Juvenile rheumatoid arthritis: therapeutic perspectives. Paediatr Drugs. 2002, 4: 335-348. DOI: 10.2165/00128072-200204050-00006
20. Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED: Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. J Rheumatol. 2002, 29: 1071-1078.
21. Bommireddy R, Ormsby I, Yin M, Boivin GP, Babcock GF, Doetschman T: TGFbeta1 inhibits Ca(2+)-calcineurin-mediated activation in thymocytes. J Immunol. 2003, 170: 3645-3652. DOI: 10.4049/jimmunol.170.7.3645
22. Khalkhali-Ellis Z, Bulla GA, Schlesinger LS, Kirschmann DA, Moore TL, Hendrix MJ: C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors. J Immunol. 1999, 163: 4612-4620.
23. De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A: Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol. 1999, 26: 425-431.
24. Kirel B, Yetgin S, Saatci U, Ozen S, Bakkaloglu A, Besbas N: Anaemia in juvenile chronic arthritis. Clin Rheumatol. 1996, 15: 236-241. DOI: 10.1007/BF02229700
25. Wakisaka S, Suzuki N, Takeno M, Takeba Y, Nagafuchi H, Saito N, Hashimoto H, Tomita T, Ochi T, Sakane T: Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis. Ann Rheum Dis. 1998, 57: 487-494. DOI: 10.1136/ard.57.8.487
26. Matsunaga T, Ishida T, Takekawa M, Nishimura S, Adachi M, Imai K: Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes. Scand J Immunol. 2002, 56: 593-601. 10.1046/j.1365-3083.2002.01179.x. DOI: 10.1046/j.1365-3083.2002.01179.x
27. Lopez S, Halbwachs-Mecarelli L, Ravaud P, Bessou G, Dougados M, Porteu F: Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin Exp Immunol. 1995, 101: 25-32. DOI: 10.1111/j.1365-2249.1995.tb02272.x
28. Koyama Y, Suzuki M, Yoshida T: CD63, a member of tetraspan transmembrane protein family, induces cellular spreading by reaction with monoclonal antibody on substrata. Biochem Biophys Res Commun. 1998, 246: 841-846. 10.1006/bbrc.1998.8725. DOI: 10.1006/bbrc.1998.8725
29. Mobasheri A, Vannucci SJ, Bondy CA, Carter SD, Innes JF, Arteaga MF, Trujillo E, Ferraz I, Shakibaei M, Martin-Vasallo P: Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol. 2002, 17: 1239-1267.
30. Scola MP, Thompson SD, Brunner HI, Tsoras MK, Witte D, Van D, Grom AA, Passo MH, Glass DN: Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol. 2002, 29: 369-378.
31. Araujo V, Arnal C, Boronat M, Ruiz E, Dominguez C: Oxidant-antioxidant imbalance in blood of children with juvenile rheumatoid arthritis. Biofactors. 1998, 8: 155-159. DOI: 10.1002/biof.5520080126
32. Robinson JJ, Watson F, Bucknall RC, Edwards SW: Stimulation of reactive oxidant production in neutrophils by soluble and insoluble immune complexes occurs via different receptors/ signal transduction systems. FEMS Immunol Med Microbiol. 1994, 8: 249-257. 10.1016/0928-8244(94)90057-4. DOI: 10.1111/j.1574-695X.1994.tb00450.x
33. Amit A, Kindzelskii AL, Zanoni J, Jarvis JN, Petty HR: Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils. Cell Immunol. 1999, 194: 47-53. 10.1006/cimm.1999.1481. DOI: 10.1006/cimm.1999.1481
34. Lin SJ, Huang JL, Chao HC, Lee WY, Yang MH: A follow-up study of systemic-onset juvenile rheumatoid arthritis in children. Acta Paediatr Taiwan. 1999, 40: 176-181.
35. Sikora A, Brozik H, Sikora JP, Golebiowska M: Chemiluminescence of peripheral blood leukocytes and activity of an inflammatory process in juvenile chronic arthritis (JCA). Acta Univ Carol [Med] (Praha). 1994, 40: 75-79.
36. Egger G, Klemt C, Spendel S, Kaulfersch W, Kenzian H: Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay. Inflammation. 1994, 18: 427-441. 10.1007/BF01534440. DOI: 10.1007/BF01534440
37. Taubert H, Riemann D, Kehlen A, Meye A, Bartel F, John V, Brandt J, Bache M, Wurl P, Schmidt H, Weber E: Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis. Autoimmunity. 2002, 35: 221-224. 10.1080/08916930290031676. DOI: 10.1080/08916930290031676
38. Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Trabandt A, Keysser M, Gay RE, Gay S: Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum. 1995, 38: 976-984. DOI: 10.1002/art.1780380714
39. Poole AR, Hembry RM, Dingle JT, Pinder I, Ring EF, Cosh J: Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. Arthritis Rheum. 1976, 19: 1295-1307. DOI: 10.1002/art.1780190610
40. Matsumoto T, Tsurumoto T: Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters. Clin Exp Rheumatol. 2001, 19: 655-660.
41. Vos K, Miltenburg AM, van Meijgaarden KE, van den Heuvel M, Elferink DG, van Galen PJ, van Hogezand RA, van Vliet-Daskalopoulou E, Ottenhoff TH, Breedveld FC, Boots AM, de Vries RR: Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions. Rheumatology (Oxford). 2000, 39: 1326-1331. 10.1093/rheumatology/39.12.1326. DOI: 10.1093/rheumatology/39.12.1326
42. Patil NS, Sonderstrup G, Mellins ED: Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells. J Immunol. 2001, 166: 33-41. DOI: 10.4049/jimmunol.166.1.33
43. Hakala BE, White C, Recklies AD: Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 1993, 268: 25803-25810.
44. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL: Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest. 2000, 106: 951-961. DOI: 10.1172/JCI10905